Regina Tardanico

4.4k total citations
76 papers, 2.1k citations indexed

About

Regina Tardanico is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Regina Tardanico has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 21 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Regina Tardanico's work include Renal cell carcinoma treatment (21 papers), Renal and related cancers (14 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Regina Tardanico is often cited by papers focused on Renal cell carcinoma treatment (21 papers), Renal and related cancers (14 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Regina Tardanico collaborates with scholars based in Italy, United States and Belgium. Regina Tardanico's co-authors include Francesco Scolari, R Maiorca, Guido Martignoni, Francesco Callea, Ezio Movilli, Battista Fabio Viola, Mario Rizzetto, Ferruccio Bonino, Roberto Rizzi and G Verme and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Regina Tardanico

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Regina Tardanico Italy 25 973 652 416 369 286 76 2.1k
Magali Colombat France 21 413 0.4× 461 0.7× 307 0.7× 359 1.0× 179 0.6× 92 1.5k
B. Mougenot France 29 547 0.6× 1.0k 1.6× 251 0.6× 238 0.6× 114 0.4× 67 3.0k
François Paraf France 29 1.2k 1.2× 912 1.4× 411 1.0× 804 2.2× 265 0.9× 117 2.9k
Emmanuelle Plaisier France 25 450 0.5× 623 1.0× 257 0.6× 160 0.4× 298 1.0× 58 2.3k
Élisabeth Diot France 33 1.8k 1.9× 488 0.7× 816 2.0× 338 0.9× 83 0.3× 113 3.8k
Jiuliang Zhao China 24 751 0.8× 286 0.4× 272 0.7× 238 0.6× 122 0.4× 231 2.3k
Mohammed Akhtar Saudi Arabia 26 1.7k 1.8× 1.3k 2.0× 241 0.6× 670 1.8× 51 0.2× 134 3.1k
Cloé Comarmond France 26 1.1k 1.2× 176 0.3× 677 1.6× 234 0.6× 857 3.0× 59 2.5k
L Guillevin France 24 2.0k 2.1× 337 0.5× 550 1.3× 362 1.0× 77 0.3× 96 3.1k
A.C. Desbois France 26 690 0.7× 158 0.2× 543 1.3× 150 0.4× 647 2.3× 57 1.9k

Countries citing papers authored by Regina Tardanico

Since Specialization
Citations

This map shows the geographic impact of Regina Tardanico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Tardanico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Tardanico more than expected).

Fields of papers citing papers by Regina Tardanico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina Tardanico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Tardanico. The network helps show where Regina Tardanico may publish in the future.

Co-authorship network of co-authors of Regina Tardanico

This figure shows the co-authorship network connecting the top 25 collaborators of Regina Tardanico. A scholar is included among the top collaborators of Regina Tardanico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina Tardanico. Regina Tardanico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jachetti, Elena, Alice Rigoni, Lucia Bongiovanni, et al.. (2016). Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β. Molecular Cancer Therapeutics. 16(2). 365–375. 11 indexed citations
2.
Sandrini, Silvio, Francesco Scolari, Silvana Savoldi, et al.. (2015). Liver Disease in Renal Transplant Patients Treated with Azathioprine or Ciclosporin. Contributions to nephrology. 51. 114–119.
3.
Gregorini, Gina, Claudia Izzi, Pietro Ravani, et al.. (2015). Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney International. 87(6). 1223–1229. 30 indexed citations
4.
Martignoni, Guido, Matteo Brunelli, Diego Segala, et al.. (2013). Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations. Modern Pathology. 27(5). 765–774. 24 indexed citations
5.
6.
Bertagna, Francesco, Simona Fisogni, Regina Tardanico, et al.. (2012). 18F-FDG PET/CT in a Patient Affected by Renal Collecting Duct (Bellini) Carcinoma. Clinical Nuclear Medicine. 37(10). 986–988.
7.
Bertagna, Francesco, F. Motta, M. Bertoli, et al.. (2012). 926 Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma. European Urology Supplements. 11(1). e926–e926a.
8.
Izzi, Claudia, Pietro Maffei, Gabriella Milan, et al.. (2011). The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. Kidney International. 79(6). 691–692. 8 indexed citations
9.
Scalvini, Tiziano, Alessandro Gambera, Regina Tardanico, et al.. (2008). Spermatogenic and Steroidogenic Impairment of the Testicle Characterizes the Hereditary Leucine-75-Proline Apolipoprotein A-I Amyloidosis. The Journal of Clinical Endocrinology & Metabolism. 93(5). 1850–1853. 8 indexed citations
10.
Cavazzana, Ilaria, et al.. (2007). [Renal involvement in systemic sclerosis].. PubMed. 24(4). 295–310. 5 indexed citations
11.
Rastaldi, Maria Pia, Giovanni Candiano, Luca Musante, et al.. (2006). Glomerular clusterin is associated with PKC-α/β regulation and good outcome of membranous glomerulonephritis in humans. Kidney International. 70(3). 477–485. 24 indexed citations
12.
Scolari, Francesco, Gianluca Caridi, Luca Rampoldi, et al.. (2004). Uromodulin storage diseases: Clinical aspects and mechanisms. American Journal of Kidney Diseases. 44(6). 987–999. 94 indexed citations
13.
Scolari, Francesco, Regina Tardanico, Alessandra Pola, et al.. (2003). Cholesterol crystal embolic disease in renal allografts. Journal of Nephrology. 16(1). 133–143. 11 indexed citations
14.
Cancarini, Giovanni, Alessandra Pola, Giuseppe Pezzotti, et al.. (2003). Recovery of renal function after right nephrectomy, cavectomy and left renal vein ligation.. PubMed. 15(2). 186–90. 8 indexed citations
15.
Sandrini, Silvio, et al.. (1998). Neoral reduces the incidence of acute rejection after renal transplantation. Transplantation Proceedings. 30(5). 1758–1759. 1 indexed citations
16.
Savoldi, Silvana, Francesco Scolari, Silvio Sandrini, et al.. (1998). Early histopathologic changes predicting long-term kidney transplant survival. Transplantation Proceedings. 30(5). 1726–1728. 2 indexed citations
17.
Movilli, Ezio, et al.. (1996). Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrology Dialysis Transplantation. 11(8). 1607–1612. 48 indexed citations
18.
Savoldi, Silvana, Francesco Scolari, Silvio Sandrini, et al.. (1988). Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.. PubMed. 20(3 Suppl 3). 777–84. 7 indexed citations
19.
Grigolato, P, Regina Tardanico, A. Benetti, Angiola Berenzi, & Vincenzo Villanacci. (1987). Adenosquamous carcinoma of the stomach. Histochemical and ultrastructural study.. PubMed. 35(2). 87–94. 2 indexed citations
20.
Rosina, F., et al.. (1985). Chronic anti-HBe hepatitis and serum HBV-DNA. A separate clinical entity. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magali Colombat Breakdown of academic impact, for papers by B. Mougenot Breakdown of academic impact, for papers by François Paraf Breakdown of academic impact, for papers by Emmanuelle Plaisier Breakdown of academic impact, for papers by Élisabeth Diot Breakdown of academic impact, for papers by Jiuliang Zhao Breakdown of academic impact, for papers by Mohammed Akhtar Breakdown of academic impact, for papers by Cloé Comarmond Breakdown of academic impact, for papers by L Guillevin Breakdown of academic impact, for papers by A.C. Desbois
Rankless by CCL
2026